Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal aerosolized nanoliposomal irinotecan (Nal-IRI) for peritoneal carcinomatosis from gastrointestinal …
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor [Phase 1]
Phase 1 trial evaluating carbon nanoparticle-loaded iron (CNSI-Fe(II)) in patients with advanced solid tumors has completed, with results po…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer [Phase 1, Phase 2]
A Phase Ib/II study is evaluating regorafenib in combination with toripalimab and albumin-bound paclitaxel as third-line therapy for advance…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating APL-101 in non-small cell lung cancer with MET exon 14 skipping mutations and MET dysregulation, as well as other M…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer [Phase 2]
This Phase 2 clinical trial update from TME Pharma explores olaptesed pegol in combination with pembrolizumab and either nanoliposomal irino…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) [Phase 2]
Phase 2 clinical trial update evaluating durvalumab and tremelimumab in combination with propranolol and chemotherapy for advanced hepatopan…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating hypofractionated radiotherapy combined with chemotherapy and camrelizumab as neoadjuvant therapy for pancreatic can…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. [Phase 2]
This Phase 2 trial assesses the feasibility of an early palliative care intervention for patients with metastatic cancer. The study has comp…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer [Phase 1]
Phase 1 trial update for huCART-meso plus VCN-01 in pancreatic cancer and serous ovarian cancer; the study is currently active but not recru…
-
CLINICAL_TRIALS withdrawal · 2025-06-25Clinical Trial Update: TCR1020-CD8 T Cells in KRAS-mutated Cancers [Phase 1]
Phase 1 study of TCR1020-CD8 T cells for KRAS-mutated cancers has been withdrawn, involving metastatic pancreatic cancer and colorectal canc…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
A Yonsei University-led clinical trial investigates diagnosing multiple cancers and monitoring minimal residual disease using blood-based, h…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Laparotomy, Laparoscopy, da Vinci System
Completed clinical trial evaluating laparotomy, laparoscopy, and robotic da Vinci System approaches for stomach and pancreatic neoplasms, as…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers [NA]
A completed clinical trial evaluating walking as a postoperative recovery and quality-of-life intervention for older adults with lung or gas…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
An exploratory study evaluating duodenal fluid-based biomarkers for the early diagnosis of pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy [NA]
Ongoing clinical trial assessing predictive risk factors for pancreatic fistula after pancreaticoduodenectomy in patients with pancreatic or…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan
A completed clinical trial analyzing survival rates and treatment costs for pancreatic cancer patients treated with liposomal irinotecan, us…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers [Phase 2]
Phase 2 clinical trial update for Tripegfilgrastim to reduce severe neutropenia in patients with unresectable pancreatic cancer and unresect…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Evolution of Body Connection After Surgery
The study investigating post-surgical body connection in pancreatic cancer patients has completed.
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China
A planned real-world study of liposomal irinotecan (Onivyde)-based therapy for locally advanced or metastatic pancreatic cancer in China; th…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source [Phase 1, Phase 2]
An initial feasibility study (Phase 1/Phase 2) is evaluating a planar low-dose-rate (LDR) source to treat borderline resectable pancreatic c…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
This clinical trial update indicates recruitment is ongoing to assess ablation of unresectable pancreatic cancer using the NanoKnife irrever…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands [Phase 1]
Phase 1 clinical trial update of LGK974, a Wnt pathway inhibitor, in malignancies dependent on Wnt ligands; the study included several cance…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Management of Symptomatic Advanced Pancreatic Adenocarcinoma [NA]
This update notes a GERCOR-sponsored trial on management and supportive care for symptomatic advanced pancreatic adenocarcinoma, currently A…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients [Phase 2]
A Phase 2 trial is evaluating a metronomic capecitabine/oxaliplatin regimen with UGT1A1 genotype-directed irinotecan in metastatic pancreati…